Executives
-
Wolk Joseph JExec VP, CFO -
Mulholland KristenEVP, Chief HR Officer
-
Decker Robert JVP Corporate Controller
-
Broadhurst VanessaEVP, Global Corp Affairs
-
Reed John CEVP, Innovative Medicine, R&D
-
Wengel Kathryn EEVP, Chief TO and Risk Officer
-
Schmid TimothyEVP, WW Chair, MedTech
-
Hait WilliamEVP, Chief EI and Med Officer
-
Swanson James D.EVP, CIO
-
Forminard ElizabethExecutive VP, General Counsel
-
Duato JoaquinCEO and Chairman of the Board
-
Fasolo PeterExec VP, Chief HR Officer
?
Broadhurst Vanessa
EVP, Global Corp Affairs
Johnson & Johnson
US, New Brunswick [HQ]
CIK
1904787
Data Source
We automatically created this profile. The information was aggregated based on earnings call transcripts, insider forms and DEF 14A statements.
Latest Information
Shares :
250,810,000
Price per Share :
$147.03
Equivalence :
$36,876,594,300.00
Transaction History
-
M250,810,000 Shares After TransactionValue : $n/a$0.0Transaction Date : 02/12/24
-
Footnotes
-
-
Footnotes:#1 Awarded under Issuer's Long-Term Incentive Plan. Performance Share Units awarded on February 8, 2021; converted into shares of Common Stock upon vesting of Performance Share Units and certification of performance results by the Board on February 12, 2024.#2 Shares earned due to performance factor of 116.8% upon certification of performance results by the Board.#3 Shares withheld for payment of taxes upon vesting of Performance Share Units and certification of performance results by the Board.
-
A258,710,000 Shares After TransactionValue : $n/a$0.0Transaction Date : 02/12/24
-
Footnotes
-
-
Footnotes:#1 Awarded under Issuer's Long-Term Incentive Plan. Performance Share Units awarded on February 8, 2021; converted into shares of Common Stock upon vesting of Performance Share Units and certification of performance results by the Board on February 12, 2024.#2 Shares earned due to performance factor of 116.8% upon certification of performance results by the Board.#3 Shares withheld for payment of taxes upon vesting of Performance Share Units and certification of performance results by the Board.
-
F237,350,000 Shares After TransactionValue : $37,358,890,000.00$3,362,064,000.00Transaction Date : 02/12/24
-
Footnotes
-
-
Footnotes:#1 Awarded under Issuer's Long-Term Incentive Plan. Performance Share Units awarded on February 8, 2021; converted into shares of Common Stock upon vesting of Performance Share Units and certification of performance results by the Board on February 12, 2024.#2 Shares earned due to performance factor of 116.8% upon certification of performance results by the Board.#3 Shares withheld for payment of taxes upon vesting of Performance Share Units and certification of performance results by the Board.
-
M241,430,000 Shares After TransactionValue : $n/a$0.0Transaction Date : 02/13/24
-
Footnotes
-
-
Footnotes:#1 The Restricted Share Units awarded on February 13, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The Restricted Share Units converted into shares of Common Stock upon vesting.#2 Shares withheld for payment of taxes upon vesting of Restricted Share Units.
-
F239,340,000 Shares After TransactionValue : $37,779,819,000.00$329,906,500.00Transaction Date : 02/13/24
-
Footnotes
-
-
Footnotes:#1 The Restricted Share Units awarded on February 13, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The Restricted Share Units converted into shares of Common Stock upon vesting.#2 Shares withheld for payment of taxes upon vesting of Restricted Share Units.